Christine von Weizsäcker participated in the European Expert Meeting in Preparation of the Twenty-first Meeting of SBSTTA.
Christine von Weizsäcker, Helena Paul, Antje Lorch and Ricarda Steinbrecher participated in the Thirteens Conference of the Parties to the Convention on Biological Diversity, (COP 13), the Eighth Meeting of the Parties to the Cartagena Protocol on Biosafety (MOP 8) and the Second Meeting of the Parties to the Nagoya Protocol on Access and Benefit Sharing (MOP 2) in Cancun, Mexico.
Christine von Weizsäcker, Ricarda Steinbrecher and Helena Paul participated in a workshop on Synthetic Biology organized by the ETC Group and the Heinrich-Böll-Foundation.
Christine von Weizsäcker and other ECOROPA members participated in the First meeting of the Subsidiary Body on Implementation of the Convention on Biological Diversity.
The event also included meetings with representatives of other civil society organisations and of Indigenous and Peoples and Local Communities.
Christine von Weiszäcker and other ECOROPA members participated in the Twentieth meeting of the Subsidiary Body on Scientific, Technological and Technical Advice to the Convention on Biological Diversity (SBSTTA 20).
The event also included several strategy meetings with other NGOs, as well as the organisation and participation in two side events on „The Relationship between the Cartagena Protocol on Biosafety and Synthetic Biology – relevance to the Convention on Biological Diversity“ and on „Terminator and Gene Drives“.
Ecoropa organized an International Expert Workshop on „Recent Developments in Synthetic Biology – Strategies for Environmental Risk Assessment“ with Christine von Weizsäcker and Ricarda Steinbrecher and other invited experts.
Christine von Weizsäcker participated in the conference “Governing Biotech 2.0: How Synthetic Biology will Impact Rights, Lievlihoods and Life” and in its panel discussion “Governing/Regulating Synthetic Biology and Genome Editing”. The conference was organized by ETC-Group, Synenergene and the International Union of Foodworkers.
ECO 50, Issue 2; published at COP12
The CBD has a major decision to make on synthetic biology at COP12. A great deal rests on it. Synthetic biology includes a number of modern biotechnology techniques, including many from standard genetic engineering. However, it goes beyond them in its use of human-made, computer-generated and often highly novel DNA, RNA and amino acids. It is difficult enough to assess the risks around genetic engineering, but synthetic biology greatly increases the level of complexity and the number of